In short Monsanto, the world’s biggest seed company, sought to rely on a European patent for its Roundup Ready soy beans as a means of preventing the importation into the European Union of soy meal from Argentina. The question at the heart of the dispute was whether the patent, for soy beans that are resistant to some herbicides (notably Roundup), extends to soy meal made from the patented seeds. Argentina, the world’s third-biggest soy bean exporter after Brazil and the US, is one of the few countries in which Monsanto had no patent coverage for its herbicide-resistant seeds.
In 2005-2006 Monsanto had a quantity of soy meal from Argentina impounded in Amsterdam harbour. Tests showed that the impounded product contained some of the patented seed traits, so Monsanto sued the importers for infringement. A Dutch court, hearing the dispute in 2008, sought the guidance of the Court of Justice. According to the Advocate General, protection for patents that cover genetic sequences was limited to situations in which the genetic information was actually performing the functions described, which it wasn't doing in the case of soy beans which had been turned into meal. Today the Court of Justice ruled as follows:
"1. Article 9 of Directive 98/44 ... on the legal protection of biotechnological inventions is to be interpreted as not conferring patent right protection in circumstances ... in which the patented product is contained in the soy meal, where it does not perform the function for which it is patented, but did perform that function previously in the soy plant, of which the meal is a processed product, or would possibly again be able to perform that function after it had been extracted from the soy meal and inserted into the cell of a living organism.The IPKat is fascinated to know what stratagems Monsanto will adopt next, given that this ruling cannot be appealed and is applicable across all 27 European Union Member States. Within its sector, Monsanto's actions will be carefully studied since not only that company but its competitors have looked to what is now held to be an improperly extended notion of patent protection for their income streams. The company is more IP-savvy than most and is bound to have Plan B, Plan C and Plan D lined up. Merpel says, it's easier to create a soy bean that's resistant to herbicides than a patent that's resistant to soy meal importers ...
2. Article 9 of the Directive effects an exhaustive harmonisation of the protection it confers, with the result that it precludes the national patent legislation from offering absolute protection to the patented product as such, regardless of whether it performs its function in the material containing it.
3. Article 9 of the Directive precludes the holder of a patent issued prior to the adoption of that directive from relying on the absolute protection for the patented product accorded to it under the national legislation then applicable.
4. Articles 27 and 30 of [TRIPS]... do not affect the interpretation given of Article 9 of the Directive".
Hmmm win some loose some I guess.
ReplyDeleteMonsanto expanded the scope of patent protection for gene patents in Canada on their last trip to our Supreme Court. Monsanto Canada Inc. v. Schmeiser, 2004 SCC 34, [2004] 1 S.C.R. 902
I suspect though that Monsanto would wish they had their success in the EU rather than CA given the relative market sizes.
Will this decision lead to countries with weaker patents, or weaker gene based patent protection developing specialization as 'generic crop' exporters?